Ascendis Pharma (ASND) Rated as a Hold at Cannacord Genuity on Growth Hormone Prospects
Gilead (GILD) Downplays FDA Decision to Pause HIV Combination Trial over Safety Concern
Cigna (CI) Unveils AI-Powered Tools to Enhance Healthcare Delivery
Morgan Stanley Hikes Labcorp (LH) Holdings Price Target to $283 Affirms ‘Overweight’ Rating